-
公开(公告)号:US06221660B1
公开(公告)日:2001-04-24
申请号:US09387699
申请日:1999-08-13
IPC分类号: C12N518
CPC分类号: C07K14/705
摘要: This invention provides isolated nucleic acids encoding mammalian SNORF25 receptors, purified mammalian SNORF25 receptors, vectors comprising nucleic acid encoding mammalian SNORF25 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF25 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian SNORF25 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF25 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian SNORF25 receptors, methods of isolating mammalian SNORF25 receptors, methods of treating an abnormality that is linked to the activity of the mammalian SNORF25 receptors, as well as methods of determining binding of compounds to mammalian SNORF25 receptors, methods of identifying agonists and antagonists of SNORF25 receptors, and agonists and antagonists so identified.
摘要翻译: 本发明提供了编码哺乳动物SNORF25受体的分离的核酸,纯化的哺乳动物SNORF25受体,包含编码哺乳动物SNORF25受体的核酸的载体,包含此类载体的细胞,针对哺乳动物SNORF25受体的抗体,用于检测编码哺乳动物SNORF25受体的核酸的核酸探针, 与编码哺乳动物SNORF25受体的核酸的独特序列互补的反义寡核苷酸,表达编码正常或突变的哺乳动物SNORF25受体的DNA的转基因非人动物,分离哺乳动物SNORF25受体的方法,治疗与哺乳动物的活性相关的异常的方法 SNORF25受体以及确定化合物与哺乳动物SNORF25受体的结合的方法,识别SNORF25受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。
-
公开(公告)号:US07416848B2
公开(公告)日:2008-08-26
申请号:US10278437
申请日:2002-10-22
IPC分类号: G01N33/53 , C07K14/705 , C07H21/04
CPC分类号: C07K14/705
摘要: This invention provides isolated nucleic acids encoding mammalian SNORF25 receptors, purified mammalian SNORF25 receptors, vectors comprising nucleic acid encoding mammalian SNORF25 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF25 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian SNORF25 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF25 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian SNORF25 receptors, methods of isolating mammalian SNORF25 receptors, methods of treating an abnormality that is linked to the activity of the mammalian SNORF25 receptors, as well as methods of determining binding of compounds to mammalian SNORF25 receptors, methods of identifying agonists and antagonists of SNORF25 receptors, and agonists and antagonists so identified.
摘要翻译: 本发明提供了编码哺乳动物SNORF25受体的分离的核酸,纯化的哺乳动物SNORF25受体,包含编码哺乳动物SNORF25受体的核酸的载体,包含此类载体的细胞,针对哺乳动物SNORF25受体的抗体,用于检测编码哺乳动物SNORF25受体的核酸的核酸探针, 与编码哺乳动物SNORF25受体的核酸的独特序列互补的反义寡核苷酸,表达编码正常或突变的哺乳动物SNORF25受体的DNA的转基因非人动物,分离哺乳动物SNORF25受体的方法,治疗与哺乳动物的活性相关的异常的方法 SNORF25受体以及确定化合物与哺乳动物SNORF25受体的结合的方法,识别SNORF25受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。
-
3.
公开(公告)号:US06468756B1
公开(公告)日:2002-10-22
申请号:US09641259
申请日:2000-08-17
IPC分类号: G01N3353
CPC分类号: C07K14/705
摘要: This invention provides isolated nucleic acids encoding mammalian SNORF25 receptors, purified mammalian SNORF25 receptors, vectors comprising nucleic acid encoding mammalian SNORF25 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF25 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian SNORF25 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF25 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian SNORF25 receptors, methods of isolating mammalian SNORF25 receptors, methods of treating an abnormality that is linked to the activity of the mammalian SNORF25 receptors, as well as methods of determining binding of compounds to mammalian SNORF25 receptors, methods of identifying agonists and antagonists of SNORF25 receptors, and agonists and antagonists so identified.
摘要翻译: 本发明提供了编码哺乳动物SNORF25受体的分离的核酸,纯化的哺乳动物SNORF25受体,包含编码哺乳动物SNORF25受体的核酸的载体,包含此类载体的细胞,针对哺乳动物SNORF25受体的抗体,用于检测编码哺乳动物SNORF25受体的核酸的核酸探针, 与编码哺乳动物SNORF25受体的核酸的独特序列互补的反义寡核苷酸,表达编码正常或突变的哺乳动物SNORF25受体的DNA的转基因非人动物,分离哺乳动物SNORF25受体的方法,治疗与哺乳动物的活性相关的异常的方法 SNORF25受体以及确定化合物与哺乳动物SNORF25受体的结合的方法,识别SNORF25受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。
-
-